Robert McNeil has over thirty-five years of experience as an active investor and management participant in seed and early-stage biomedical companies. He founded Sanderling Ventures in 1979 and has served since then as a Managing Director of Sanderling’s seven investment partnerships.
Dr. McNeil has been an active investor for over sixty early stage investments for Sanderling Ventures. In each case, close relationships with management and careful understanding of the companies’ technologies have allowed successful development of products at very early stage. He has played an active role in these seed companies and has helped many to graduate to late stage status where they either were purchased or affected public offerings.
Dr. McNeil earned his Ph.D. in the fields of molecular biology, biochemistry and genetics in 1972 from the University of California, Irvine.